The remote control of PMN formation by the primary tumor secretome presents the opportunity for circulating PMN-inducing biomarker detection and monitoring (MMPs, TIMPs, LOX, and EVs) in liquid biopsies from patients. The gene discussed is LOX; the disease is neoplasm.